AzTrials
AzTrials

Breast CancerNCT05576545

Develop and Evaluate the Effectiveness of a Self-Care Smartphone Application on the Self-Efficacy, and Resilience Among Newly Diagnosed Breast Cancer Patients Undergoing Treatment

A study testing The Breast Cancer Self-Care App in people with Breast Cancer and Breast Neoplasm, run by Kaohsiung Medical University Chung-Ho Memorial Hospital at 1 site in Taiwan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study was to develop and evaluate the self-efficacy and resilience of the Breast Cancer Self-Care App in newly diagnosed breast cancer patients undergoing chemotherapy. Read more about this study

Who is it for?
Ages 20 to 65 years
What is being tested?
The Breast Cancer Self-Care App
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
73 participants
Where
1 siteTaiwan
Study dates
18 Sep 2020to 15 Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Consciousness clear, over 20 years old, can communicate in Mandarin and Taiwanese
  • Diagnosed Breast Cancer I-III stage
  • undergo first chemotherapy
  • Have a smartphone
  • Receiving treatment: EC/ EC+T/LC/LC+T E: (Epirubicin)、C: (Cyclophosphamide)、L: (Lipo-Dox)、T: (Taxotere)

Who cannot join

  • DSM-V mentally ill
  • IOS system smartphone
  • over 65 years old

Trial locations and contacts

1 site in 1 country.

Taiwan1 site

  • Kaohsiung Medical University

    Kaohsiung City, 807

Other trials in Taiwan

About this study

This study was to develop and evaluate the self-efficacy and resilience of the Breast Cancer Self-Care App in newly diagnosed breast cancer patients undergoing chemotherapy.

Read the detailed description

This study was to develop and evaluate the self-efficacy and resilience of the Breast Cancer Self-Care App in newly diagnosed breast cancer patients undergoing chemotherapy. In the first phase of this study, develop a prototype the Breast Cancer Self-Care App by conducting patients interviews. In the second phase, an experimental two-group pretest-posttest quantitative study design to evaluate the self-efficacy and resilience of the Breast Cancer Self-Care App in newly diagnosed breast cancer patients undergoing chemotherapy. The patients were randomized to the experimental and control groups. Patients in the control group received general routine care and patients in the experimental group received general routine care plus the Breast Cancer Self-Care App intervention. Both groups completed a basic demographics, self-efficacy and resilience questionnaires at the pre-test and after four weeks.

Being tested
The Breast Cancer Self-Care App
Keywords
Breast cancer, mobile application, Resilience, self-efficacy
Medical subject headings
Breast Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The Breast Cancer Self-Care AppDevice

    The Breast Cancer Self-Care App includes several parts- introduction to breast cancer, types of treatment, side effects care, nutrition, relaxation videos, insurance, medical news and recording side effects, etc. The researcher assisted in installing the App on the patient's mobile phone, entered the personal account, and asked the patient to fill in questionnaires. Patients were given individual health education task in the Breast Cancer Self-Care App every week according to the type of chemotherapy drugs. After four weeks, they filled in questionnaires again.

Study groups in NCT05576545
Study groupRoleWhat they receive
general routine care and the Breast Cancer Self-Care AppExperimentalNot described
Receives: Device: The Breast Cancer Self-Care App
general routine careNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self-efficacy

    Use Strategies Used by People to Promote Health (SUPPH) measure self-care self-efficacy. The scale total of 29 items measure self-care self-efficacy. There are 3 sub subscales for each of the following: Stress Reduction (10 items, 5-50scores), Making Decisions (3 items, 3-15scores), Positive Attitude (16 items,16-80 scores). The range of total scores of the scale is 29-145. It shows that self-care self-efficacy increases as total points of the scale increase.

    Measured: 4 weeks

Secondary outcomes (1)

  1. Resilience

    Use Resilience scale 14 items (RS-14) measure individual resilience. The scale with a total of 14 items measures resilience. The range of total scores of the scale is 14-98. It shows that resilience increases as total points of the scale increase.

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Oct 2022
  2. Study start18 Sep 2020
  3. Primary completion15 Aug 2022
  4. Study completion15 Aug 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
73 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05576545
Sponsor's protocol ID
KMUHIRB-E(I)-20200041
Status last verified
Oct 2022
First submitted
26 Sep 2022
Last updated
12 Oct 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Aizpurua-Perez I, Perez-Tejada J. Resilience in women with breast cancer: A systematic review. Eur J Oncol Nurs. 2020 Dec;49:101854. doi: 10.1016/j.ejon.2020.101854. Epub 2020 Oct 10.

    PubMed 33120216

  • Ajčević, M., Dea, F. D., Barbieri, G., & Accardo, A. (2019). A mobile app for the self-management of type 1 diabetes as tool for preventing of exercise-associated glycemic imbalances. World Congress on Medical Physics and Biomedical Engineering 475-479. https://doi.org/10.1007/978-981-10-9035-6_88

  • Akin S, Can G, Durna Z, Aydiner A. The quality of life and self-efficacy of Turkish breast cancer patients undergoing chemotherapy. Eur J Oncol Nurs. 2008 Dec;12(5):449-56. doi: 10.1016/j.ejon.2008.07.006. Epub 2008 Oct 7.

    PubMed 18842460

  • Akin S, Kas Guner C. Investigation of the relationship among fatigue, self-efficacy and quality of life during chemotherapy in patients with breast, lung or gastrointestinal cancer. Eur J Cancer Care (Engl). 2019 Jan;28(1):e12898. doi: 10.1111/ecc.12898. Epub 2018 Jul 24.

    PubMed 30039883

  • Aungst TD, Clauson KA, Misra S, Lewis TL, Husain I. How to identify, assess and utilise mobile medical applications in clinical practice. Int J Clin Pract. 2014 Feb;68(2):155-62. doi: 10.1111/ijcp.12375.

    PubMed 24460614

  • Awan A, Esfahani K. Endocrine therapy for breast cancer in the primary care setting. Curr Oncol. 2018 Aug;25(4):285-291. doi: 10.3747/co.25.4139. Epub 2018 Aug 14.

    PubMed 30111969

  • Ayyoubzadeh SM, Shirkhoda M, R Niakan Kalhori S, Mohammadzadeh N, Zakerabasali S. A Smartphone Remote Monitoring App to Follow Up Colorectal Cancer Survivors: Requirement Analysis. JMIR Cancer. 2022 Jan 5;8(1):e18083. doi: 10.2196/18083.

    PubMed 34989685

  • Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977 Mar;84(2):191-215. doi: 10.1037//0033-295x.84.2.191. No abstract available.

    PubMed 847061

  • Bandura, A. (1982). Self-efficacy mechanism in human agency. American psychologist, 37(2), 122. https://doi.org/10.1037/0003-066X.37.2.122

  • Bandura, A. (1986). The explanatory and predictive scope of self-efficacy theory. Journal of Social and Clinical Psychology, 4(3), 359-373. https://doi.org/10.1521/jscp.1986.4.3.359

  • Bandura, A. (2010). Self-efficacy the corsini encyclopedia of psychology. John Wiley & Sons, 10, 1-3. https://doi.org/10.1002/9780470479216.corpsy0836

  • Bandura, A., Freeman, W., & Lightsey, R. (1999). Self-efficacy: The exercise of control. 15-17. https://doi.org/10.1007/BF02352723

  • Baumel A, Torous J, Edan S, Kane JM. There is a non-evidence-based app for that: A systematic review and mixed methods analysis of depression- and anxiety-related apps that incorporate unrecognized techniques. J Affect Disord. 2020 Aug 1;273:410-421. doi: 10.1016/j.jad.2020.05.011. Epub 2020 May 11.

    PubMed 32560936

  • Britton WB. Can mindfulness be too much of a good thing? The value of a middle way. Curr Opin Psychol. 2019 Aug;28:159-165. doi: 10.1016/j.copsyc.2018.12.011. Epub 2019 Jan 7.

    PubMed 30708288

  • Buneviciene I, Mekary RA, Smith TR, Onnela JP, Bunevicius A. Can mHealth interventions improve quality of life of cancer patients? A systematic review and meta-analysis. Crit Rev Oncol Hematol. 2021 Jan;157:103123. doi: 10.1016/j.critrevonc.2020.103123. Epub 2020 Oct 20.

    PubMed 33190065

Questions about this trial

What is this clinical trial studying?

A study testing The Breast Cancer Self-Care App in people with Breast Cancer and Breast Neoplasm, run by Kaohsiung Medical University Chung-Ho Memorial Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self-efficacy (time frame: 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05576545, which also lists 65 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Oct 2022.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in